Response Genetics (RGDXQ) Stock Price & Analysis
RGDXQ Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.01
- Previous Close
- $0.01
- Volume
- 4,300
- Average Volume (3M)
- 0
- Market Cap
- $39
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- $9.09M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- 0.0
- Beta
- 0.28
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
RGDXQ FAQ
What was Response Genetics’s price range in the past 12 months?
What is Response Genetics’s market cap?
When is Response Genetics’s upcoming earnings report date?
Is Response Genetics overvalued?
Does Response Genetics pay dividends?
What is Response Genetics’s EPS estimate?
How many shares outstanding does Response Genetics have?
Which hedge fund is a major shareholder of Response Genetics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Response Genetics
Response Genetics, Inc., a life sciences company founded in Los Angeles, California, in 1999 (originally Bio Type, Inc., before its rebranding in August 2000), focuses on creating, advancing, and commercializing pharmacogenomic tests. These diagnostic tools are crucial for informing cancer treatment decisions by assessing specific indicators within tumor tissue samples that predict a patient's response to therapy. The company provides an extensive array of testing services, primarily through its ResponseDX suite, covering various cancers such as non-small cell lung, colorectal, gastric, gastroesophageal, melanoma, thyroid, breast, and glioma, in addition to a Tissue of Origin test. Beyond these existing solutions, Response Genetics is committed to expanding its diagnostic offerings to encompass other tumor types, while also delivering both the technical execution and professional interpretation components of its testing services. Operating globally, with a significant presence in the United States and Europe, Response Genetics serves a wide range of clients including community oncologists, pathologists, medical practices, hospitals, and pharmaceutical enterprises, primarily through its internal sales force.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Thomas Bologna
- Employees
- 96
- Website
- www.responsegenetics.com
- Address
- 1640 Marengo Street, Los Angeles, CA, 90033, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 4 |
| Technical Analysis | 2 | 1 | 0 |
| Moving Averages | 2 | 2 | 4 |